RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.970
EU - Europa 14.122
AS - Asia 10.915
SA - Sud America 1.560
AF - Africa 210
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 22
Totale 55.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.726
GB - Regno Unito 4.933
IT - Italia 3.836
CN - Cina 3.731
SG - Singapore 3.157
HK - Hong Kong 1.650
SE - Svezia 1.365
BR - Brasile 1.294
DE - Germania 892
UA - Ucraina 625
RU - Federazione Russa 623
TR - Turchia 622
VN - Vietnam 526
FI - Finlandia 485
KR - Corea 327
FR - Francia 324
BG - Bulgaria 240
IN - India 207
NL - Olanda 151
ID - Indonesia 149
CA - Canada 116
AR - Argentina 101
IE - Irlanda 98
JP - Giappone 92
ZA - Sudafrica 81
RO - Romania 80
ES - Italia 79
BE - Belgio 78
MX - Messico 74
PL - Polonia 67
BD - Bangladesh 60
LT - Lituania 53
IQ - Iraq 52
PK - Pakistan 48
EC - Ecuador 44
IR - Iran 44
CH - Svizzera 37
AE - Emirati Arabi Uniti 35
EG - Egitto 31
CO - Colombia 30
CZ - Repubblica Ceca 27
AT - Austria 26
AU - Australia 26
MA - Marocco 26
IL - Israele 25
MY - Malesia 22
UZ - Uzbekistan 22
VE - Venezuela 21
PY - Paraguay 19
CL - Cile 18
GR - Grecia 18
PT - Portogallo 18
EU - Europa 16
UY - Uruguay 15
JO - Giordania 13
SA - Arabia Saudita 12
SN - Senegal 12
TN - Tunisia 12
TW - Taiwan 12
DZ - Algeria 11
TH - Thailandia 11
AZ - Azerbaigian 10
HU - Ungheria 10
AL - Albania 9
KE - Kenya 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
PE - Perù 9
DK - Danimarca 8
JM - Giamaica 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
NO - Norvegia 7
NP - Nepal 7
AM - Armenia 6
CR - Costa Rica 6
EE - Estonia 6
LA - Repubblica Popolare Democratica del Laos 6
LK - Sri Lanka 6
OM - Oman 6
PH - Filippine 6
ET - Etiopia 5
LB - Libano 5
PA - Panama 5
PS - Palestinian Territory 5
RS - Serbia 5
BZ - Belize 4
HN - Honduras 4
KH - Cambogia 4
LV - Lettonia 4
MD - Moldavia 4
NG - Nigeria 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
YE - Yemen 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
Totale 55.776
Salva come PNG Salva come JPEG
Città #
Southend 3.817
Santa Clara 2.734
Fairfield 2.349
Ashburn 2.341
Singapore 1.900
Chandler 1.757
Woodbridge 1.635
Hong Kong 1.634
Hefei 1.332
Jacksonville 1.265
Chicago 1.089
Houston 1.084
Seattle 997
Wilmington 991
Dearborn 954
Ann Arbor 918
Cambridge 795
Nyköping 775
Los Angeles 676
Beijing 674
London 619
Modena 537
San Jose 468
Salt Lake City 382
Izmir 355
Seoul 274
New York 267
Princeton 249
Helsinki 239
The Dalles 235
Sofia 234
Dallas 230
Eugene 219
Council Bluffs 217
San Diego 212
Milan 196
Tampa 178
Ho Chi Minh City 171
Elk Grove Village 162
Moscow 160
Rome 159
Bologna 154
Buffalo 148
Shanghai 138
Munich 126
São Paulo 121
Des Moines 118
Jakarta 112
Redwood City 112
Hanoi 109
Lancaster 105
Bremen 94
Falls Church 88
Fremont 88
Dublin 84
Frankfurt am Main 76
Columbus 75
Reggio Emilia 73
Tokyo 73
Brussels 71
Miami 70
Sterling 69
Phoenix 67
Naples 58
Florence 55
Dulles 54
Guangzhou 52
Orem 51
Parma 49
Stockholm 49
Boardman 47
Brooklyn 45
Detroit 45
Nanjing 44
Turin 44
Warsaw 44
Como 42
Atlanta 40
Johannesburg 40
Chennai 39
Kent 37
Norwalk 37
Catania 36
Denver 35
Kansas City 35
Rio de Janeiro 35
Montreal 33
Tulare 33
Napoli 32
Toronto 32
Bari 31
Amsterdam 30
Boston 30
Kunming 30
Redondo Beach 30
Poplar 29
Jinan 28
Pittsburgh 28
Belo Horizonte 27
Changsha 27
Totale 39.084
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 516
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 464
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 448
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 433
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 411
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 407
Cationic liposomes for gene transfection 394
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 394
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 391
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 388
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 386
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 384
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 381
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 378
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 375
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 372
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 365
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 359
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 359
Amphiphilic ion pairs of tobramycin with lipoamino acids 359
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 354
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 352
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 348
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 348
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 343
Nanomedicine: the future for advancing medicine and neuroscience 337
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 336
Vegetable cells in Papanicolaou-stained cervical smears 334
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 333
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 333
Polymeric nanoparticles for the drug delivery to the central nervous system 328
Brain targeting with polymeric nanoparticles: which administration route should we take? 327
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 324
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 321
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 319
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 318
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 317
Nanoparticle transport across the blood brain barrier 317
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 315
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 314
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 311
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 309
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 305
Protein corona and nanoparticles: How can we investigate on? 305
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 304
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 303
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 301
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 298
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 297
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 294
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 293
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 289
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 289
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 289
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 287
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. 285
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 284
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 284
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 283
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 282
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 281
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 280
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 278
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 278
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 278
Colloidal systems for CNS drug delivery 274
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 273
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 273
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 273
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 272
PLA/PLGA nanoparticles for sustained release of docetaxel 272
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 271
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 270
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 267
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 265
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 265
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 264
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 262
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 262
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 261
Functionalization of liposomes: microscopical methods for preformulative screening 260
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 258
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 256
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 255
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 255
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 253
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 252
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 249
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 248
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 243
Ketorolac tromethamine liposomes: Encapsulation and release studies 242
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 241
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 239
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 238
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 236
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 234
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 231
Application of poly-L-lactide screws in flat foot surgery: Histological and radiological aspects of bio-absorption of degradable devices 231
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 230
Blood-Brain Barrier crossing of high molecular weight molecules mediated by nanoparticles: a potential approach to treat neurological Lysosomal Storage Disorders 228
Totale 30.772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 222.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 222.577
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.985 0 0 0 0 0 0 487 701 255 899 365 278
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/202511.116 526 176 238 820 2.136 1.467 897 755 1.082 503 1.148 1.368
2025/202612.848 1.329 851 1.566 2.785 4.348 1.379 590 0 0 0 0 0
Totale 56.243